A diet-induced mouse model for glutaric aciduria type I.

In the autosomal recessive human disease, glutaric aciduria type I (GA-1), glutaryl-CoA dehydrogenase (GCDH) deficiency disrupts the mitochondrial catabolism of lysine and tryptophan. Affected individuals accumulate glutaric acid (GA) and 3-hydroxyglutaric acid (3-OHGA) in the serum and often suffer acute striatal injury in childhood. Prior attempts to produce selective striatal vulnerability in an animal model have been unsuccessful. We hypothesized that acute striatal injury may be induced in GCDH-deficient (Gcdh-/-) mice by elevated dietary protein and lysine. Here, we show that high protein diets are lethal to 4-week-old and 8-week-old Gcdh-/- mice within 2-3 days and 7-8 days, respectively. High lysine alone resulted in vasogenic oedema and blood-brain barrier breakdown within the striatum, associated with serum and tissue GA accumulation, neuronal loss, haemorrhage, paralysis, seizures and death in 75% of 4-week-old Gcdh-/- mice after 3-12 days. In contrast, most 8-week-old Gcdh-/- mice survived on high lysine, but developed white matter lesions, reactive astrocytes and neuronal loss after 6 weeks. Thus, the Gcdh-/- mouse exposed to high protein or lysine may be a useful model of human GA-1 including developmentally dependent striatal vulnerability.

[1]  S. Kölker,et al.  Bioenergetics in Glutaryl-Coenzyme A Dehydrogenase Deficiency , 2005, Journal of Biological Chemistry.

[2]  C. Bührer,et al.  Glutaric Acid and Its Metabolites Cause Apoptosis in Immature Oligodendrocytes: A Novel Mechanism of White Matter Degeneration in Glutaryl-CoA Dehydrogenase Deficiency , 2005, Pediatric Research.

[3]  M. D. Del Bigio,et al.  Neuropathological, biochemical and molecular findings in a glutaric acidemia type 1 cohort. , 2005, Brain : a journal of neurology.

[4]  K. Strauss Glutaric aciduria type 1: a clinician's view of progress. , 2005, Brain : a journal of neurology.

[5]  K. Strauss,et al.  Vascular dysfunction as an additional pathomechanism in glutaric aciduria type I , 2004, Journal of Inherited Metabolic Disease.

[6]  M. R. Bigio,et al.  Preliminary attempts to establish a rat model of striatal injury in glutaric acidaemia type I , 2004, Journal of Inherited Metabolic Disease.

[7]  K. Strauss,et al.  Challenges for basic research in glutaryl-CoA dehydrogenase deficiency , 2004, Journal of Inherited Metabolic Disease.

[8]  R. Ramsay,et al.  Carnitine acyltransferases and their influence on CoA pools in health and disease. , 2004, Molecular aspects of medicine.

[9]  Takeshi Kimura,et al.  Thirteen-Week Oral Toxicity Study of L-Lysine Hydrochloride in Rats , 2004, International journal of toxicology.

[10]  J. Walecki,et al.  MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy. , 2003, Hepato-gastroenterology.

[11]  K. Strauss,et al.  Type I glutaric aciduria, part 2: A model of acute striatal necrosis , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[12]  E. Puffenberger,et al.  Type I glutaric aciduria, part 1: Natural history of 77 patients , 2003, American journal of medical genetics. Part C, Seminars in medical genetics.

[13]  G. Hoffmann,et al.  Adult onset glutaric aciduria type I presenting with a leukoencephalopathy , 2003, Neurology.

[14]  J. Dichgans,et al.  Adult onset glutaric aciduria type I presenting with a leukoencephalopathy , 2002, Neurology.

[15]  E. Puffenberger,et al.  Diagnosis and treatment of maple syrup disease: a study of 36 patients. , 2002, Pediatrics.

[16]  J. Hoeijmakers,et al.  Premature Aging in Mice Deficient in DNA Repair and Transcription , 2002, Science.

[17]  B. Kleinschmidt-DeMasters,et al.  Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. , 2002, Human molecular genetics.

[18]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[19]  Vincent Schmithorst,et al.  Simultaneous correction of ghost and geometric distortion artifacts in EPI using a multiecho reference scan , 2001, IEEE Transactions on Medical Imaging.

[20]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[21]  C. Palmeira,et al.  Induction of the mitochondrial permeability transition in vitro by short-chain carboxylic acids. , 2000, Biochemical and Biophysical Research Communications - BBRC.

[22]  F. Condé,et al.  Major strain differences in response to chronic systemic administration of the mitochondrial toxin 3-nitropropionic acid in rats: implications for neuroprotection studies , 2000, Neuroscience.

[23]  B. Ahlemeyer,et al.  Maturation-Dependent Neurotoxicity of 3-Hydroxyglutaric and Glutaric Acids In Vitro : A New Pathophysiologic Approach to Glutaryl-CoA Dehydrogenase Deficiency , 2000, Pediatric Research.

[24]  Q. Smith Transport of glutamate and other amino acids at the blood-brain barrier. , 2000, The Journal of nutrition.

[25]  T W Gardner,et al.  Effect of vascular endothelial growth factor on cultured endothelial cell monolayer transport properties. , 2000, Microvascular research.

[26]  G. Sutherland,et al.  Serial magnetic resonance imaging of rat brain after induction of renal hypertension. , 1999, Stroke.

[27]  J. Marrero,et al.  Azoxymethane-induced fulminant hepatic failure in C57BL/6J mice: characterization of a new animal model. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[28]  E. Christensen,et al.  Glutaric aciduria type I: Pathomechanisms of neurodegeneration , 1999, Journal of Inherited Metabolic Disease.

[29]  T. Crenshaw,et al.  Mitochondrial lysine uptake limits hepatic lysine oxidation in rats fed diets containing 5, 20 or 60% casein. , 1998, The Journal of nutrition.

[30]  M. Wajner,et al.  Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid , 1998, Brain Research.

[31]  D. Morton,et al.  Diagnosis and management of glutaric aciduria type I , 1998, Journal of Inherited Metabolic Disease.

[32]  A. Morton,et al.  Changes in blood–brain barrier permeability following neurotoxic lesions of rat brain can be visualised with trypan blue , 1998, Journal of Neuroscience Methods.

[33]  F. Podo,et al.  Transient global brain ischemia in the rat: spatial distribution, extension, and evolution of lesions evaluated by magnetic resonance imaging , 1997, Magnetic Resonance Materials in Physics, Biology and Medicine.

[34]  B. Kreft,et al.  Subdural hemorrhage as an initial sign of glutaric aciduria type 1: A diagnostic pitfall , 1996, Pediatric Radiology.

[35]  H. Osaka,et al.  Two cases of glutaric aciduria type 1: Clinical and neuropathological findings , 1994, Journal of the Neurological Sciences.

[36]  H. Osaka,et al.  Chronic subdural hematoma, as an initial manifestation of glutaric aciduria type-1 , 1993, Brain and Development.

[37]  J. Gomori,et al.  Striatal degeneration and spongy myelinopathy in glutaric acidemia , 1992, Journal of the Neurological Sciences.

[38]  C. Stanley,et al.  Acute profound dystonia in infants with glutaric acidemia. , 1989, Pediatrics.

[39]  R K Craig,et al.  Methods in molecular medicine. , 1987, British medical journal.

[40]  M. Norenberg,et al.  Glutaric aciduria: biochemical and morphologic considerations. , 1977, The Journal of pediatrics.

[41]  S. Goodman,et al.  Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and beta-hydroxyglutarate: explanation of the symptoms in glutaric aciduria? , 1976, Clinica chimica acta; international journal of clinical chemistry.

[42]  Saul G. Cohen,et al.  Requirements for Stereospecificity in Hydrolysis by Chymotrypsin: Diethyl β-Acetamidoglutarate , 1960, Nature.

[43]  J. Winn,et al.  Brain , 1878, The Lancet.

[44]  D. Danks,et al.  Neuropathology in glutaric acidaemia type 1 , 2004, Acta Neuropathologica.

[45]  E. Wolpert,et al.  Isolation and characterization of retinal endothelial cells. , 2003, Methods in molecular medicine.

[46]  M. Pourfarzam,et al.  Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. , 2003, Neuropediatrics.

[47]  L. Hartley,et al.  Glutaric aciduria type 1 and nonaccidental head injury. , 2001, Pediatrics.

[48]  H. Taegtmeyer,et al.  Propionyl-L-carnitine-mediated improvement in contractile function of rat hearts oxidizing acetoacetate. , 1995, The American journal of physiology.

[49]  C. Greenberg,et al.  Phenotypic variability in glutaric aciduria type I: Report of fourteen cases in five Canadian Indian kindreds. , 1991, The Journal of pediatrics.

[50]  N. Benevenga,et al.  Adverse effects of excessive consumption of amino acids. , 1984, Annual review of nutrition.